Identification of genetic alterations of AXIN2 gene in adrenocortical tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages

  Chapman, Audrey ^a   Durand, Julien ^a   Ouadi, Lydia ^a   Bourdeau, Isabelle ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AXIN; BETA CATENIN; CORTICOTROPIN; HYDROCORTISONE; SERINE; WNT PROTEIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADRENAL HYPERPLASIA; ADULT; ARTICLE; AXIN2 GENE; CANCER CELL CULTURE; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AXIN PROTEIN; BETA CATENIN; CARCINOMA; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; WNT PROTEINS;

EID: 80052516759     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2987     Document Type: Article

References (19)

1. Tadjine M., Lampron A., Ouadi L., Bourdeau I. 2008 Frequent mutations of β-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 68:264-270
2. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., HagneréA.M., René-Corail F., Jullian E., Gicquel C., Bertagna X., Vacher-Lavenu M.C., Perret C., Bertherat J. 2005 Mutations of β-catenin in adrenocortical tumors: Activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65:7622-7627 (Pubitemid 41297234)
3. Masi G., Lavezzo E., Iacobone M., Favia G., Palù G., Barzon L. 2009 Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors. J Endocrinol Invest 32:597-600
4. Polakis P. 2007 The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51 (Pubitemid 46109296)
5. Behrens J., Lustig B. 2004 The Wnt connection to tumorigenesis. Int J Dev Biol 48:477-487 (Pubitemid 39360398)
6. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. 2002 Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172-1183 (Pubitemid 34094853)
7. Lammi L., Arte S., Somer M., Jarvinen H., Lahermo P., Thesleff I., Pirinen S., Nieminen P. 2004 Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74:1043-1050 (Pubitemid 38568974)
8. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., Thibodeau S.N. 2000 Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling. Nat Genet 26:146-147
9. Suraweera N., Robinson J., Volikos E., Guenther T., Talbot I., Tomlinson I., Silver A. 2006 Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int J Cancer 119:1837-1842 (Pubitemid 44356840)
10. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., Nagorney D.M., Burgart L.J., Roche P.C., Smith D.I., Ross J.A., Liu W. 2002 Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863-4871
11. Kim M.S., Kim S.S., Ahn C.H., Yoo N.J., Lee S.H. 2009 Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol 40:58-64
12. Wu R., Zhai Y., Fearon E.R., Cho K.R. 2001 Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61:8247-8255 (Pubitemid 33091619)
13. Schteingart D.E., Doherty G.M., Gauger P.G., Giordano T.J., Hammer G.D., Korobkin M., Worden F.P. 2005 Management of patients with adrenal cancer: Recommendations of an international consensus conference. Endocr Relat Cancer 12:667-680 (Pubitemid 41483000)
14. Tadjine M., Lampron A., Ouadi L., Horvath A., Stratakis C.A., Bourdeau I. 2008 Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clin Endocrinol (Oxf) 69:367-373
15. Castiglia D., Bernardini S., Alvino E., Pagani E., De Luca N., Falcinelli S., Pacchiarotti A., Bonmassar E., Zambruno G., D'Atri S. 2008 Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. Genes Chromosomes Cancer 47:614-624 (Pubitemid 351748347)
16. Pedace L., Castiglia D., De Simone P., Castori M., DeLuca N., Amantea A., Binni F., Majore S., Cozzlino A.M., De Bernardo C., Zambruno G., Catricalà C., Grammatico P. 2011 AXIN2 germline mutations are rare in familial melanoma. Genes Chromosomes Cancer 50:370-373
17. Willert K., Shibamoto S., Nusse R. 1999 Wnt-induced dephosphorylation of axin releases β-catenin from the axin complex. Genes Dev 13:1768-1773 (Pubitemid 29353044)
18. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. 1998 Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17:1371-1384
19. Koch A., Hrychyk A., Hartmann W., Waha A., Mikeska T., Waha A., Schüller U., Sörensen N., Berthold F., Goodyer C.G., Wiestler O.D., Birchmeier W., Behrens J., Pietsch T. 2007 Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int J Cancer 121:284-291 (Pubitemid 46917696)